Diamond Therapeutics to present groundbreaking study at NIH event ...Middle East

Dr. Edward Sellers, head of Diamond's clinical advisory board, will speak about the benefits of low-dose psilocybin TORONTO, May 27, 2021 /PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on sub-perceptual therapies for mental...

Hence then, the article about diamond therapeutics to present groundbreaking study at nih event was published today ( Thursday 27/05/2021 - 05:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Diamond Therapeutics to present groundbreaking study at NIH event )

Also on site :

• Jason and Travis Kelce’s ‘New Heights’ Launches Retail Hub (Exclusive)
• 11 Colorado schools receive threats, several on lockdown
• US Visa Processing Frozen By Trump Administration in 75 Countries